These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10752822)

  • 1. Thrombus formation on the balloon of heparin-bonded pulmonary artery catheters: an ultrastructural scanning electron microscope study.
    Hofbauer R; Moser D; Kaye AD; Dielacher C; Hornykewycz S; Handler S; Speiser W; Kapiotis S; Frass M
    Crit Care Med; 2000 Mar; 28(3):727-35. PubMed ID: 10752822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary artery catheter under the microscope.
    Fontes M; Barash PG
    Crit Care Med; 2000 Mar; 28(3):891-2. PubMed ID: 10752853
    [No Abstract]   [Full Text] [Related]  

  • 3. Do anticoagulation with heparin and protamine reversal alter thrombogenicity of coated and noncoated pulmonary artery catheters?
    Youngberg JA; Kaye AD; Anwar M
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4):405-9. PubMed ID: 10468252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducers and protective sleeves may increase thrombogenicity of pulmonary artery catheters.
    Kaye AD; Anwar M; Youngberg JA
    J Cardiothorac Vasc Anesth; 1999 Apr; 13(2):139-42. PubMed ID: 10230945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antithrombogenic thermodilution catheter.
    Nagaoka S; Mikami M; Noishiki Y
    J Biomater Appl; 1989 Jul; 4(1):22-32. PubMed ID: 2746466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-coated angiographic catheters: an in vivo comparison of three coating methods with different heparin release profiles.
    Lee KH; Han JK; Byun Y; Moon HT; Yoon CJ; Kim SJ; Choi BI
    Cardiovasc Intervent Radiol; 2004; 27(5):507-11. PubMed ID: 15383856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping.
    Mermel LA; McCormick RD; Springman SR; Maki DG
    Am J Med; 1991 Sep; 91(3B):197S-205S. PubMed ID: 1928165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface antimicrobial activity of heparin-bonded and antiseptic-impregnated vascular catheters.
    Mermel LA; Stolz SM; Maki DG
    J Infect Dis; 1993 Apr; 167(4):920-4. PubMed ID: 8450256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-coated catheters and heparin-induced thrombocytopenia.
    Laster J; Silver D
    J Vasc Surg; 1988 May; 7(5):667-72. PubMed ID: 3367431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombogenicity of heparin- and non-heparin-coated catheters: clinical trail.
    Kido DK; Paulin S; Alenghat JA; Waternaux C; Riley WD
    AJR Am J Roentgenol; 1982 Nov; 139(5):957-61. PubMed ID: 6751056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombogenicity of pulmonary-artery catheters.
    Mollenholt P; Eriksson I; Andersson T
    Intensive Care Med; 1987; 13(1):57-9. PubMed ID: 3558936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials.
    Randolph AG; Cook DJ; Gonzales CA; Andrew M
    Chest; 1998 Jan; 113(1):165-71. PubMed ID: 9440585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Device to limit inflation of a pulmonary artery catheter balloon.
    Westenskow DR; Silva FH
    Crit Care Med; 1993 Sep; 21(9):1365-8. PubMed ID: 8370301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased incidence of arterial thrombosis using heparin-bonded intraaortic balloons.
    Lazar HL; Bao Y; Rivers S; Treanor PR; Shemin RJ
    Ann Thorac Surg; 1999 Feb; 67(2):446-9. PubMed ID: 10197668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon.
    Nunes GL; Thomas CN; Hanson SR; Barry JJ; King SB; Scott NA
    Circulation; 1995 Oct; 92(7):1697-700. PubMed ID: 7671350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effective systematic heparin pre-treatment on thrombus formation on pulmonary artery catheter tips during pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a randomized, double-blind study.
    Wiedenroth CB; Liebetrau C; Gall H; Risch T; Arlt M; Mayer E; Guth S
    J Thromb Thrombolysis; 2017 Oct; 44(3):335-340. PubMed ID: 28875371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of heparin-bonded pulmonary artery catheters on the activated coagulation time.
    McNulty SE; Maguire DP; Thomas RE
    J Cardiothorac Vasc Anesth; 1998 Oct; 12(5):533-5. PubMed ID: 9801973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Thrombosis and Non-Heparin-Coated Pulmonary Artery Catheters.
    Cronin B; Maus T; Maruszak B; Manecke G
    J Cardiothorac Vasc Anesth; 2017 Aug; 31(4):e62-e63. PubMed ID: 28506457
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of heparinized and nonheparinized solutions for maintaining patency of arterial and pulmonary artery catheters.
    Zevola DR; Dioso J; Moggio R
    Am J Crit Care; 1997 Jan; 6(1):52-5. PubMed ID: 9116787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
    Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
    Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.